Wednesday, March 16, 2022 8:50:50 AM
I said that a long time ago and I got hit for pumping. People just have to ask, "what do YOU think the market will pay for a cancer cure? virus inhibitor?"
It's very simple where this will go IF the science is good. You have finally found the one stock on the market that is SIMPLE to predict. $cience or Zer0
100$ = 0.50$
200$ = 1.00$
500$ = 2.50$
1000$ = 5.00$
As crazy as it sounds, If we could imagine going over 5$ pre-split, why can’t we get to 1000$ if both the cancer & COVID results are positive?
REALLY, only $1,000...?
It's very simple where this will go IF the science is good. You have finally found the one stock on the market that is SIMPLE to predict. $cience or Zer0
100$ = 0.50$
200$ = 1.00$
500$ = 2.50$
1000$ = 5.00$
As crazy as it sounds, If we could imagine going over 5$ pre-split, why can’t we get to 1000$ if both the cancer & COVID results are positive?
REALLY, only $1,000...?
Recent SBFM News
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
